CR20140380A - Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina - Google Patents

Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina

Info

Publication number
CR20140380A
CR20140380A CR20140380A CR20140380A CR20140380A CR 20140380 A CR20140380 A CR 20140380A CR 20140380 A CR20140380 A CR 20140380A CR 20140380 A CR20140380 A CR 20140380A CR 20140380 A CR20140380 A CR 20140380A
Authority
CR
Costa Rica
Prior art keywords
pirazolopirimidinyl
ubiquitine
inhibitors
activating enzyme
formula
Prior art date
Application number
CR20140380A
Other languages
English (en)
Spanish (es)
Inventor
Roushan Afroze
Indu T Bharathan
Jeffrey P Ciavarri
Paul E Fleming
Jeffrey L Gaulin
Mario Girard
Steven P Langston
Francois R Soucy
Tzu-Tshin Wong
Yingchun Ye
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of CR20140380A publication Critical patent/CR20140380A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CR20140380A 2012-02-17 2014-08-12 Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina CR20140380A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261600070P 2012-02-17 2012-02-17
PCT/US2013/026113 WO2013123169A1 (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Publications (1)

Publication Number Publication Date
CR20140380A true CR20140380A (es) 2014-10-28

Family

ID=48982730

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140380A CR20140380A (es) 2012-02-17 2014-08-12 Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina

Country Status (30)

Country Link
US (4) US9290500B2 (enExample)
EP (3) EP3173413B1 (enExample)
JP (1) JP6122877B2 (enExample)
KR (1) KR20140123104A (enExample)
CN (1) CN104136399B (enExample)
AR (1) AR092797A1 (enExample)
BR (1) BR112014020365B1 (enExample)
CA (1) CA2864672C (enExample)
CL (1) CL2014002181A1 (enExample)
CO (1) CO7071135A2 (enExample)
CR (1) CR20140380A (enExample)
DO (1) DOP2014000187A (enExample)
EA (1) EA035020B1 (enExample)
EC (1) ECSP14019113A (enExample)
ES (1) ES2739150T3 (enExample)
GE (1) GEP201706687B (enExample)
HK (1) HK1201817A1 (enExample)
IL (1) IL234016A0 (enExample)
MA (1) MA35932B1 (enExample)
MX (1) MX352963B (enExample)
NZ (1) NZ628969A (enExample)
PE (1) PE20142244A1 (enExample)
PH (1) PH12014501832A1 (enExample)
SG (2) SG10201606581RA (enExample)
TN (1) TN2014000351A1 (enExample)
TW (1) TWI593688B (enExample)
UA (1) UA116534C2 (enExample)
UY (1) UY34629A (enExample)
WO (1) WO2013123169A1 (enExample)
ZA (1) ZA201406103B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
EP3173413B1 (en) 2012-02-17 2019-05-01 Millennium Pharmaceuticals, Inc. Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
WO2014022744A1 (en) 2012-08-03 2014-02-06 Millennium Pharmaceuticals, Inc. INDOLE-SUBSTITUTED PYRROLOPYRIMIDINYL INHIBITORS OF Uba6
BR112015032902A8 (pt) 2013-07-02 2019-12-24 Millennium Pharm Inc compostos de heteroarila, seus usos e composições farmacêuticas
EP3901159A1 (en) * 2014-07-01 2021-10-27 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
TW201628621A (zh) * 2014-10-29 2016-08-16 千禧製藥公司 泛素活化酶抑制劑及輻射之施用
EP3212650B1 (en) 2014-10-29 2021-02-17 Millennium Pharmaceuticals, Inc. Administration of ubiquitin-activating enzyme inhibitor and chemotherapeutic agents
MY210039A (en) 2018-10-30 2025-08-22 Kronos Bio Inc Compounds, compositions, and methods for modulating cdk9 activity
CN117412973A (zh) * 2021-05-31 2024-01-16 上海瑛派药业有限公司 含氮稠合杂芳双环化合物作为usp1抑制剂及其应用
WO2023021498A1 (en) * 2021-08-16 2023-02-23 Moya Bio Ltd. Fused azole and furan based nucleoside analogs and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023901A1 (en) 2002-02-28 2004-02-05 Cook Phillip D. Nucleoside 5'-monophosphate mimics and their prodrugs
WO2004022559A1 (en) 2002-09-04 2004-03-18 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7196092B2 (en) 2002-09-04 2007-03-27 Schering Corporation N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
CN1701073B (zh) 2002-09-04 2011-06-22 先灵公司 作为细胞周期蛋白依赖激酶抑制剂的吡唑并[1,5-a]嘧啶
US7563798B2 (en) 2002-09-04 2009-07-21 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
EP1608652A1 (en) 2003-03-31 2005-12-28 Vernalis (Cambridge) Limited Pyrazolopyrimidine compounds and their use in medicine
JP2005008581A (ja) 2003-06-20 2005-01-13 Kissei Pharmaceut Co Ltd 新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
US20050130974A1 (en) 2003-10-17 2005-06-16 Rigel Pharmaceuticals, Inc. Benzothiazole compositions and their use as ubiquitin ligase inhibitors
JP2008503591A (ja) 2004-06-22 2008-02-07 ライジェル ファーマシューティカルズ, インコーポレイテッド ユビキチンリガーゼ阻害剤
AU2006210422B2 (en) 2005-02-04 2012-09-13 Takeda Pharmaceutical Company Limited Inhibitors of E1 activating enzymes
WO2007044426A2 (en) 2005-10-06 2007-04-19 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
CN106008512B (zh) 2006-02-02 2019-03-12 千禧药品公司 E1活化酶抑制剂
JP4953472B2 (ja) * 2006-02-28 2012-06-13 ラム・リサーチ・アクチエンゲゼルシヤフト ディスク状物品を液体処理する装置及び方法
HRP20110017T1 (hr) * 2006-08-08 2011-02-28 Millennium Pharmaceuticals Spojevi heteroarila korisni kao inhibitori e1 aktivirajućih enzima
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
JP5539864B2 (ja) 2007-06-12 2014-07-02 アカオゲン,インコーポレーテッド 抗菌剤
KR101925902B1 (ko) * 2007-08-02 2018-12-06 밀레니엄 파머슈티컬스 인코퍼레이티드 E1 활성화 효소 억제제의 합성 방법
WO2009082691A1 (en) 2007-12-21 2009-07-02 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
WO2010086040A1 (en) 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
WO2010088518A2 (en) 2009-01-31 2010-08-05 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
SG10201402148SA (en) * 2009-05-14 2014-07-30 Millennium Pharm Inc Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
EP3064204A1 (en) 2010-03-01 2016-09-07 GTx, Inc. Compounds for treatment of cancer
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
MX2014002015A (es) 2011-08-24 2014-03-27 Millennium Pharm Inc Inhibidores de la enzima activadora de nedd8.
EP3173413B1 (en) 2012-02-17 2019-05-01 Millennium Pharmaceuticals, Inc. Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
WO2014022744A1 (en) 2012-08-03 2014-02-06 Millennium Pharmaceuticals, Inc. INDOLE-SUBSTITUTED PYRROLOPYRIMIDINYL INHIBITORS OF Uba6
BR112015032902A8 (pt) 2013-07-02 2019-12-24 Millennium Pharm Inc compostos de heteroarila, seus usos e composições farmacêuticas
EP3901159A1 (en) 2014-07-01 2021-10-27 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme

Also Published As

Publication number Publication date
US10202389B2 (en) 2019-02-12
ZA201406103B (en) 2017-11-29
US9663525B2 (en) 2017-05-30
JP6122877B2 (ja) 2017-04-26
CO7071135A2 (es) 2014-09-30
MA35932B1 (fr) 2014-12-01
ES2739150T3 (es) 2020-01-29
US20130217682A1 (en) 2013-08-22
EP2814791A1 (en) 2014-12-24
CN104136399A (zh) 2014-11-05
CA2864672A1 (en) 2013-08-22
PE20142244A1 (es) 2015-01-07
PH12014501832A1 (en) 2014-11-17
US9290500B2 (en) 2016-03-22
UA116534C2 (uk) 2018-04-10
KR20140123104A (ko) 2014-10-21
HK1201817A1 (en) 2015-09-11
EP3173413B1 (en) 2019-05-01
BR112014020365A2 (pt) 2020-12-22
US20170369499A1 (en) 2017-12-28
TW201345909A (zh) 2013-11-16
GEP201706687B (en) 2017-06-26
DOP2014000187A (es) 2014-10-15
EP3173413A1 (en) 2017-05-31
EA201400831A1 (ru) 2014-12-30
WO2013123169A1 (en) 2013-08-22
NZ628969A (en) 2017-03-31
SG10201606581RA (en) 2016-09-29
TWI593688B (zh) 2017-08-01
US20160244455A1 (en) 2016-08-25
US20170217968A1 (en) 2017-08-03
MX352963B (es) 2017-12-15
US9796725B2 (en) 2017-10-24
AR092797A1 (es) 2015-05-06
EP2814791A4 (en) 2015-08-19
TN2014000351A1 (en) 2015-12-21
EP3536692B1 (en) 2021-04-07
CL2014002181A1 (es) 2014-12-12
MX2014009944A (es) 2014-11-10
IL234016A0 (en) 2014-09-30
JP2015508775A (ja) 2015-03-23
UY34629A (es) 2013-09-02
US20140088096A9 (en) 2014-03-27
CN104136399B (zh) 2018-08-07
EA035020B1 (ru) 2020-04-17
BR112014020365B1 (pt) 2023-02-23
EP3536692A1 (en) 2019-09-11
CA2864672C (en) 2018-01-09
ECSP14019113A (es) 2015-09-30
SG11201404757WA (en) 2014-09-26

Similar Documents

Publication Publication Date Title
CR20140380A (es) Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
EA201590224A1 (ru) Имидазотриазинкарбонитрилы, используемые в качестве ингибиторов киназы
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
UA110338C2 (xx) Хімічні сполуки
BR112013016595A2 (pt) inibidores de neprilisina
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
UA111382C2 (uk) Інгібітори протеїнкінази
EA201792021A1 (ru) Ингибитор jak
EA201290880A1 (ru) Новые соединения - ингибиторы фермента
UY34092A (es) Nuevos compuestos como inhibidores de jak
UY34216A (es) Nuevos compuestos que inhiben la actividad de la Lp-PLA2
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
EA201490724A1 (ru) Замещенные соединения тетрагидроизохинолина в качестве ингибиторов фактора xia
UY34445A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
UY34559A (es) Inhibidores de bromodominios
UY33958A (es) Inhibidores de la glucosilceramida sintasa
UY34851A (es) Inhibidores macrocíclicos de virus flaviviridae
UY33937A (es) Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
UA113062C2 (xx) Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону
HUE054473T2 (hu) Eljárás HIV-integráz inhibitor hatású vegyületek elõállítására
CR20130539A (es) Triazolopiridinas
IN2014CN04558A (enExample)
EA201492210A1 (ru) Соединения, ингибирующие активность катехол-o-метилтрансферазы